December 03, 2019
Story at-a-glance
- Opioid overdoses kill more than 130 people in the U.S. daily in an unprecedented crisis that continues to spiral out of control
- Purdue Pharma, which manufactures OxyContin, was instrumental in driving up sales of the drug to close to $2 billion a year by 2004
- As it became clear that people were dying from opioids, Purdue Pharma engaged in extensive damage-control tactics, including suggesting that the people dying from opioids were already drug addicts
- Purdue Pharma hired notorious PR firm Dezenhall Resources, which helped spread the opioid anti-story — the idea that pain patients who may lose access to opioids were the true victims of the opioid crisis
- In September 2019, Purdue Pharma filed Chapter 11 bankruptcy as part of a deal to settle the more than 2,000 lawsuits it’s currently facing
- Mundipharma, which is selling OxyContin in China, is using many of the same marketing tactics Purdue Pharma is now being accused of
Opioid overdoses kill more than 130 people in the U.S. daily1
in an unprecedented crisis that continues to spiral out of control. The
pharmaceutical companies behind these drugs are now facing mounting
lawsuits, as it's become clear that they're the ones with blood on their
proverbial hands, having pushed drugs on unsuspecting pain patients
while knowing they were unsafe.
From 1999 to 2017, more than 702,000 people died from a drug overdose and, in 2017, this was a leading cause of injury-related deaths in the U.S. Of the 70,000 drug-overdose deaths that occurred that year, 68% involved opioids.2
Purdue Pharma, which manufactures OxyContin, was instrumental in driving up sales of the drug to close to $2 billion a year by 2004,3 and as it became clear that people were dying as a result, they engaged in every damage-control tactic they could think of, even suggesting that the only people dying from opioids were already drug addicts.
In a major exposé by ProPublica, the lengths Purdue Pharma went to downplay OxyContin's risks are revealed. In short, ProPublica senior reporter David Armstrong wrote, "OxyContin's makers delayed the reckoning for their role in the opioid crisis by funding think tanks, placing friendly experts on leading outlets, and deterring or challenging negative coverage."4
Read and learn more here>>>https://articles.mercola.com/sites/articles/archive/2019/12/03/opioid-producers-put-blame-on-addicts.aspx?cid_source=dnl&cid_medium=email&cid_content=art2HL&cid=20191203Z1&et_cid=DM402953&et_rid=762391121
From 1999 to 2017, more than 702,000 people died from a drug overdose and, in 2017, this was a leading cause of injury-related deaths in the U.S. Of the 70,000 drug-overdose deaths that occurred that year, 68% involved opioids.2
Purdue Pharma, which manufactures OxyContin, was instrumental in driving up sales of the drug to close to $2 billion a year by 2004,3 and as it became clear that people were dying as a result, they engaged in every damage-control tactic they could think of, even suggesting that the only people dying from opioids were already drug addicts.
In a major exposé by ProPublica, the lengths Purdue Pharma went to downplay OxyContin's risks are revealed. In short, ProPublica senior reporter David Armstrong wrote, "OxyContin's makers delayed the reckoning for their role in the opioid crisis by funding think tanks, placing friendly experts on leading outlets, and deterring or challenging negative coverage."4
Read and learn more here>>>https://articles.mercola.com/sites/articles/archive/2019/12/03/opioid-producers-put-blame-on-addicts.aspx?cid_source=dnl&cid_medium=email&cid_content=art2HL&cid=20191203Z1&et_cid=DM402953&et_rid=762391121
Kindly Use this tips to Overcome Opiate addiction
ReplyDeleteThis topic has been explained in such a marvelous way, where each and everyone can be aware of this addiction.
ReplyDeleteOpiate Withdrawal Stages And Timeline
This article is useful.Outpatient rehab near me do check our blog,Thanks.
ReplyDelete